Concepedia

Ivo Nnane

IN

Statistics

Publications

29

Citations

1.2K

H-Index

18

Active since

1998

Affiliations

Janssen (United States)(Current)

University of Maryland, Baltimore

Janssen (Belgium)

Springhouse

Temple University

Ivo Nnane is an author at Janssen (United States) specializing in pharmacology, medicine, and pharmacy.

Publications per year

1998–2024

29

Publications

29

CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab

Ganesh Raghu, Fernando J. Martínez, Kevin K. Brown et al. · European Respiratory Journal · 2015 · 149 citations · Full text

, , +16

A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate

Josef S Smolen, Sandeep K. Agarwal, Xie L. Xu et al. · Annals of the Rheumatic Diseases · 2017 · 143 citations · Full text

, , +16

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof‐of‐concept study

Gideon M. Hirschfield, M. Eric Gershwin, Marlyn J. Mayo et al. · Hepatology · 2015 · 132 citations

, , +17

Novel 17-Azolyl Steroids, Potent Inhibitors of Human Cytochrome 17α-Hydroxylase-C<sub>17,20</sub>-lyase (P450<sub>17</sub><sub>α</sub>):  Potential Agents for the Treatment of Prostate Cancer

Vincent C.O. Njar, Katsuya Kato, Ivo Nnane et al. · Journal of Medicinal Chemistry · 1998 · 120 citations · Full text

, , +9

The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats

Ge Lin, Ivo Nnane, Tin-Yan Cheng · Toxicon · 1999 · 84 citations

, , +8

1–5 of 29